Cas:136195-53-4 2-Amino-4-chloro-1,3-thiazole-5-carbonitrile manufacturer & supplier

We serve Chemical Name:2-Amino-4-chloro-1,3-thiazole-5-carbonitrile CAS:136195-53-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Amino-4-chloro-1,3-thiazole-5-carbonitrile

Chemical Name:2-Amino-4-chloro-1,3-thiazole-5-carbonitrile
CAS.NO:136195-53-4
Synonyms:2-amino-4-chloro-5-cyanopyrrolo<2,3-d>pyrimidine;2-amino-4-chloro-5-cyano-7H-pyrrolo[2,3-d]pyrimidine;2-amino-4-chlorothiazole-5-carbonitrile;2-amino-4-chloro-5-cyanothiazole
Molecular Formula:C4H2ClN3S
Molecular Weight:159.59700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:376.7ºC at 760 mmHg
Density:1.63g/cm3
Index of Refraction:1.653
PSA:91.67000
Exact Mass:158.96600
LogP:1.18048

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-amino-4-chloro-5-cyanopyrrolo&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-amino-4-chloro-5-cyanothiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pyrimidine Use and application,2-amino-4-chlorothiazole-5-carbonitrile technical grade,usp/ep/jp grade.


Related News: Such investment is by no means prohibitive and can reap substantial rewards that include shorter development timelines, lower costs, faster time to market, and game changing technological advantage for sustainable competitive edge. 5-(4-(3-(2-((4-chlorophenoxy)methyl)-4-methyl-1H-benzo[d]imidazol-1-yl)propyl)piperidin-1-yl)pentan-2-one manufacturers One way of leveraging the many benefits of biocatalysis is to partner with an API CDMO offering comprehensive expertise and experience in developing and implementing such technology in GMP commercial production. 3-ethyl-5,6,7,8-tetrahydroquinolin-5-amine hydrochloride suppliers Since it emerged as a shareholder of GSK in April, Elliott has reportedly been trying to gin up investor support to move Walmsley to the consumer health spinoff rather than to let her lead the new GSK after the separation. 1,1′,4,4′-Tetramethoxy(2,2′-bianthryl)-9,10:9′,10′-dichinon vendor & factory.